Abstract
Some neutralizing antibodies against HIV-1 envelope proteins were highly effective to inhibit the infection of different strainsin vitro, and existed in the infected individuals with very low levels. We suggested multi-epitope-vaccine as a new strategy to increase levels of neutralizing antibodies and the abilities against HIV mutationin vivo. Two candidate multi-epitope-vaccines induced antibodies with predefined multi-epitope-specificity in rhesus macaque. These antibodies recognized corresponding neutralizing epitopes on epitope-peptides, gp41 peptides, V3 loop peptide, rsgp41 and rgp120. Besides, three candidate epitope-vaccines in combination (another kind of multi-epitopevaccines) showed similar potency to induce predefined multiple immune responses in rabbits. These results suggest that multi-epitope-vaccines may be a new strategy to induce multi-antiviral activities against HIV-1 infection and mutations.
Similar content being viewed by others
References
Connor, R. I., Korber, B. T. M., Graham, B. S. et al., Immunological and virological analyses of persons infected by human-immunodeficiency-virus type-1 while participating in trials of recombinant gp120 subunit vaccines, J. Virol., 1998, 72: 1552.
Muster, T., Steindl, F., Purtscher, M., A conserved neutralizing epitope on gp41 of human immunodeficiency virus type I, J. Virol., 1993, 67: 6642.
Moore, J. P., Burton, D. R., HIV-1 neutralizing antibodies: How full is the bottle? Nature Med., 1999, 5: 142.
Chen, Y. H., Xiao, Y., Yu, T. W. et al., Epitope-vaccine: a new strategy against HIV-1, Immunology Today, 1999, 20: 588.
Igarashi, T., Brown, C., Azadegan, A. et al., Human immunodeficiency yirus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma, Nature Med., 1999, 5: 211.
Montefiori, D. C., Reimann, K. A., Wyand, M. S. et al., Neutralizing antibodies in sera from macaques infected with chimeric siman-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency type, J. Virol., 1998, 72: 3427.
Geffin, R. B., Scott, G. B., Melenwick, M. et al., Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1, AIDS Res. Hum. Retroviruses, 1998, 14: 579.
Catasti, P., Bradbury, E. M., Gupta, G., Structure and polymorphism of HIV-1 third variable loops, J. Biol. Chem., 1995, 271: 8236.
Emini, E. A., Schleif, W. A., Nunberg, J. H. et al., Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody, Nature, 1992, 355: 728.
Chen, Y. H., Dierich, M. P., A common epitope on gp41, IFN-α and IFN-β induces protective activity, Immunology Today, 1998, 19: 586.
Polacino, P. S., Stallard, V., Klaniecki, J. E. et al., Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIV in protection against homologous cloned and uncloned virus challenge in Macaques, J. Virol., 1999, 73(10): 8201.
Lewis, M. G., Elkins, W. R., McCutchan, F. E. et al., Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection, Vaccine, 1993, 11: 1347.
Chan, D. C., Fass, D., Berger, J. M., Core structure of gp41 from the HIV envelope glycoprotein. Cell, 1997, 89: 263.
Lacasse, R. A., Follis, K. E., Trahey, M., Fusion-competent vaccines: broad neutralization of primary isolates of HIV, Science, 1999, 283: 357.
Chen, Y. H., Yu, T. W., Bai, Y. et al., Immunogenicity of the GPGRAFY-epitope on synthetic peptides, Immunology Letters, 1999, 69: 353.
Tian, H. J., Xiao, Y., Zhu, M. et al., HIV epitope-peptides in aluminum adjuvant induced high levels of epitope-specific antibodies, International Immunopharmacology, 2001, 1: 763.
Yu, T. W., Bai, Y., Dierich, M. P. et al., Induction of high levels of epitope-specific antibodies by epitope/peptide candidate vaccines against Human Immunodeficiency Virus type I (HIV-1), Microbiology and Immunology, 2000, 44(2): 105.
Lu, Y., Xiao, Y., Ding, J. et al., Multiepitope vaccines intensively increased levels of antibodies recognizing three neutralizing epitopes of Human Immunodeficiency Virus-1 envelope protein, Scand. J. Immunol., 2000, 51(5): 497.
Chong, P., Chan, N., Kandil, A. et al., A strategy for rational design of fully synthetic glycopeptide conjugate vaccines, Infection and Immunity, 1997, 65: 4918.
Lu, Y., Xiao, Y., Ding, J. et al., Immunogenicity of neutralizingepitopes on multiple-epitope vaccines against HIV-1, Int. Arch. Allergy. Immunol., 2000, 121: 80.
Mascola, J. R., Stiegler, G., VanCott, T. C. et al., Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies, Nat. Med., 2000, 6: 207.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ding, J., He, F., Lu, Y. et al. Induction of multi-epitopespecific antibodies against HIV-1 by multi-epitopevaccines. Chin.Sci.Bull. 46, 1859–1864 (2001). https://doi.org/10.1007/BF02901157
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02901157